Structure-activity relationships of novel, highly potent, selective, and orally active CCR1 antagonists.
Xie YF, Lake K, Ligsay K, Komandla M, Sircar I, Nagarajan G, Li J, Xu K, Parise J, Schneider L, Huang D, Liu J, Dines K, Sakurai N, Barbosa M, Jack R.
Xie YF, et al. Among authors: huang d.
Bioorg Med Chem Lett. 2007 Jun 15;17(12):3367-72. doi: 10.1016/j.bmcl.2007.03.104. Epub 2007 Apr 5.
Bioorg Med Chem Lett. 2007.
PMID: 17446072